New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
BioCardia, Inc. (BCDA) vs Passage Bio, Inc. (PASG)
- BioCardia, Inc. BCDA 0.79 +2.60%
- Passage Bio, Inc. PASG 3.92 +8.59%
BioCardia, Inc. and Passage Bio, Inc. are both Biotechnology companies. BioCardia, Inc. and Passage Bio, Inc. are of similar size ($11.7M and $11.6M). Across the 8 metrics below, BioCardia, Inc. leads on 6 and Passage Bio, Inc. on 2.
Valuation
Profitability
| Metric | BCDA | PASG | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 70.18% |
| Operating margin | (2,010.75%) | — | 0.00% |
| Net margin | (1,999.77%) | — | 0.00% |
| Free cash flow margin | — | — | 0.00% |
| Return on equity | (443.27%) | (212.27%) | (51.58%) |
| Return on assets | (166.46%) | (69.68%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack